Methods Development
Nanoform and Takeda Collaborate on Pre-Clinical Development of Innovative Plasma-Derived Therapies
Nanoform Finland Plc ("Nanoform"), the medicine performance-enhancing company, announced that it is to enter into a pre-clinical development agreemen...
August 16, 2024 | News
Andelyn Biosciences Partners with Broad Institute to Enhance Gene Therapy Platform with MyoAAV Plasmids
Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has entere...
August 07, 2024 | News
Full-Life Technologies and SK Biopharmaceuticals Ink $571.5 Million Deal for Exclusive Rights to Radiopharmaceutical FL-091
Full-Life Technologies ("Full-Life"), a fully integrated global radiotherapeutics company, announced that it has entered into a license agreement wit...
July 17, 2024 | News
AGC Biologics Completes Production of VAR2 Pharmaceuticals' Cancer-Targeting Antibodies
AGC Biologics announced the completion of work with VAR2 Pharmaceuticals on the production of the company’s two antibody candidates targeti...
April 25, 2024 | News
GC Cell and BioCentriq® Execute Process Transfer Agreement in Anticipation of the U.S. entry of Immuncell-LC Inj
Immuncell-LC Inj. is an autologous Cytokine Induced Killer (CIK) cell therapy approved for Commercial use in South Korea as an adjuvant cell th...
February 27, 2024 | News
Charles River and Wheeler Bio Forge Strategic Alliance to Streamline Drug Development Process
This partnership aims to enhance therapeutic discovery and expedite the journey to Investigational New Drug (IND) submission by combining Charles R...
February 23, 2024 | News
WuXi XDC and Celltrion Collaborate on Comprehensive Antibody-Drug Conjugate (ADC) Services
Under the collaboration, Celltrion will delegate WuXi XDC as primary service provider on each of the integrated projects, from process development to GMP m...
January 24, 2024 | News
Bora Pharmaceuticals Expands Globally with $210 Million Acquisition of Upsher-Smith
BioPharma APAC Perspective: Bora's acquisition of Upsher-Smith for $210 million marks a pivotal moment for the pharmaceutical giant. This strategic move n...
January 18, 2024 | News
WuXi Biologics and BioNTech Partner on Monoclonal Antibody Research Agreement
Under the terms of the agreement, WuXi Biologics leverages its proprietary antibody discovery technology platforms (R in CRDMO) to discover two undisclosed...
January 11, 2024 | News
AGC announces strategic expansion of its Biopharmaceutical CDMO capability in Yokohama, Japan, signaling a new era of innovation and growth
This expansion has been selected by the Japanese Ministry of Economy, Trade and Industry (METI) as part of its "Developing biopharmaceutical manufacturin...
December 26, 2023 | News
WuXi Vaccines Passes First GMP Audit by a Global Vaccine Leader
The three-day comprehensive audit covered the CDMO site's drug substance (DS) facility, drug product (DP) facility, QC laboratories, warehouse, and utiliti...
December 07, 2023 | News
WuXi Biologics Achieves Breakthrough Productivity of ~6 g/L/day in Integrated Continuous Process at Pilot Scale
By leveraging WuXiUPTM, WuXi Biologics has completed its first end-to-end continuous drug substance (DS) manufacturing from perfused cell culture...
November 23, 2023 | News
Aragen Commissions state-of-the-art Formulations Manufacturing Facility in India
This state-of-the-art facility, set up at an investment of USD 3Mn, is located at the Mallapur Campus in Hyderabad and spans over 12,000 square feet area. ...
October 20, 2023 | News
Navin Fluorine International Ltd. unveils "Navin Molecular" as the new brand for its innovative CDMO business
The new brand is being launched to showcase the broad platform that Navin Molecular can offer and will focus on two key value propositions. Firstly, ...
October 17, 2023 | News
Most Read
- Biotech and Biopharma Industry Trends: What to Watch for in 2024
- Revolutionizing Drug Discovery: 15 AI Companies to Watch in 2024
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2024
- 2024's Biopharma Roadmap: Top 24 Biopharma Trends to Watch in 2024
- Breakthroughs Unveiled: A Year of Groundbreaking Novel Drug Approvals in 2023
- Revolutionizing Tomorrow: Top 24 Emerging Biotech Innovations to Watch in 2024
Bio Jobs
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
- Cordlife Accelerates Lab and Technical Staff Recruitment to Rebuild Foundation and Strengthen Core Processes in Singapore
- Padraig McDonnell Takes Helm as Agilent Technologies' New CEO, Pledges to Elevate Scientific Impact
- Agilent Singapore and Malaysia Hosts CEO Transition Event: Celebrating Leadership and Welcoming New CEO
- Leica Microsystems Announces Vacancy for Senior Imaging FPGA Testing Engineer in Singapore
- Glen Godresse Takes Helm as CEO of Menarini Asia-Pacific
News
Editor Picks
